Profiling how immune cells interact with tumor cells
LF-TIMING: Large-scale label-free profiling of cell-cell interactions
This study is testing a new way to look at how immune cells and tumor cells interact, which could help us understand cancer better and improve treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cellchorus INC. NIH-funded |
| Lab location | 1 site (Houston, UNITED STATES) |
| Project ID | NIH-11008612 on NIH RePORTER |
What this research studies
This research focuses on developing a new technology to quantitatively analyze the interactions between immune cells and tumor cells on a large scale. By using a novel assay called TIMING™, the researchers aim to measure various aspects of these interactions, including how often cells come into contact, how long they stay in contact, and the behaviors that lead to cell death. This approach allows for the simultaneous study of multiple investigational probes, enhancing our understanding of cell communication and behavior in cancer. Patients may benefit from insights gained that could lead to improved immunotherapy strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who may benefit from enhanced immunotherapy treatments.
Not a fit: Patients with non-cancerous conditions or those not receiving immunotherapy may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies for cancer patients by improving our understanding of how immune cells interact with tumors.
How similar studies have performed: Other research has shown success in using advanced imaging techniques to study cell interactions, suggesting that this approach has the potential for significant breakthroughs.
Where this research is happening
Houston, UNITED STATES
- Cellchorus INC. — Houston, United States (Active)
Researchers
- Principal investigator: Berdeaux, Rebecca L — Cellchorus INC.
- Study coordinator: Berdeaux, Rebecca L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.